Search - tctmd.com

Displaying 581 - 600 of 648

Sort: Relevancy | Date

Presentation GI2 2012

How to Deal with TAVR Complications

Presenter: Martin B. Leon

April 11, 2012

Presentation PCI Outcomes 2012

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

Presenter: Martin B. Leon

March 23, 2012

Presentation CIT 2012

The Rewards of Setting Up Collaborative Research Initiatives

Presenter: Martin B. Leon

March 15, 2012

News Daily News

Un Estudio Sugiere TC en 3D previas a la TAVR como ‘Punto de Referencia’

Yael L. Maxwell

March 07, 2012

News Daily News

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Yael L. Maxwell

March 07, 2012

Presentation CTO 2012

Management and Outcomes for Left Main In-stent Restenosis

Presenter: Martin Leon

February 23, 2012

Presentation CTO 2012

Basic Wire Skills and Selection

Presenter: Martin Leon

February 23, 2012

Presentation CTO 2012

Dedicated Left Main Bifurcation Stents 1: Rationale, Landscape, and Development

Presenter: Martin Leon

February 22, 2012

News Industry News

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

February 19, 2012

Presentation TCT 2012

Volumetric Intravascular Ultrasound Assessment Of Mechanisms and Results Of Stent Expansion In Heart Transplant Patients.

Presenter: Elias Sanidas, Akiko Maehara, Gary S. Mintz, Takashi Kubo, Anuj Gupta, Bimmer Claessen, Diaa Hakim, Reni Rusinova, Giora Weisz, Mark A. Apfelbaum, Martin B. Leon, Martin Fahy, Jeffrey W. Moses, Donna Mancini, LeRoy E. Rabbani

January 03, 2012

Presentation TCT 2012

Safety and Efficacy of the Resolute Zotarolimus-eluting Stent in Patients ? 70 Years of Age.

Presenter: Ganesh Manoharan, Alan C. Yeung, Petr Widimsky, Franz-Josef Neumann, Patrick W. Serruys, Sigmund Silber, Stephan Windecker, Martin B. Leon, Laura Mauri, Shigeru Saito, Ian T. Meredith, Jorge Belardi

January 03, 2012

Presentation TCT 2012

Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent Implantation: A Dosimetric 3D-Intravascular Ultrasound Study.

Presenter: Hideki Kitahara, Teruyoshi Kume, Katsuhisa Waseda, Kenji Sakamoto, Ryotaro Yamada, Paul Yock, Ian T. Meredith, Martin B. Leon, Laura Mauri, Alan C. Yeung, Peter J. Fitzgerald, Yasuhiro Honda

January 03, 2012

Presentation TCT 2012

Impact of Stent Size and Length on Neointimal Hyperplasia After Resolute Zotarolimus-Eluting Stent Implantation: Insights From RESOLUTE Trials

Presenter: Ryotaro Yamada, Teruyoshi Kume, Katsuhisa Waseda, Hideki Kitahara, Kenji Sakamoto, Paul G. Yock, Ian T. Meredith, Martin B. Leon, Laura Mauri, Aran C. Yeung, Yasuhiro Honda, Peter J. Fitzgerald

January 03, 2012

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu, Jie Qian, Alexandra J. Lansky, Yuejin Yang, Shubin Qiao, Yongjian Wu, Jue Chen, Fenghuan Hu, Weixian Yang, Gary S. Mintz, Martin B. Leon, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

Percutaneous Closure of the Left Atrial Appendage with the Amplatzer Cardiac Plug:Initial Latin American Experience

Presenter: An?bal A. Damonte, Costantino Costantini, Marcio Montenegro, Carlos Pedra, Alejandro Martinez, Fabio Brito, Jose Condado, Daniel Aguirre, Horacio Faella, Leon Valdivieso, Miguel Ballarino, Alejandro Fernandez, Fernando Cura

January 03, 2012

News Conference News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Conference News

Experts Remain Hopeful for the Future of Interventional Innovation

November 06, 2011

Advertisement

How to Deal with TAVR Complications

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

The Rewards of Setting Up Collaborative Research Initiatives

Un Estudio Sugiere TC en 3D previas a la TAVR como ‘Punto de Referencia’

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Management and Outcomes for Left Main In-stent Restenosis

Basic Wire Skills and Selection

Dedicated Left Main Bifurcation Stents 1: Rationale, Landscape, and Development

Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

Volumetric Intravascular Ultrasound Assessment Of Mechanisms and Results Of Stent Expansion In Heart Transplant Patients.

Safety and Efficacy of the Resolute Zotarolimus-eluting Stent in Patients ? 70 Years of Age.

Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent Implantation: A Dosimetric 3D-Intravascular Ultrasound Study.

Impact of Stent Size and Length on Neointimal Hyperplasia After Resolute Zotarolimus-Eluting Stent Implantation: Insights From RESOLUTE Trials

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Percutaneous Closure of the Left Atrial Appendage with the Amplatzer Cardiac Plug:Initial Latin American Experience

STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Complications After TAVR: Manageable, But Important to Consider

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

Experts Remain Hopeful for the Future of Interventional Innovation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content